ROYAL BANK OF CANADA - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 90 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$39,00045,026
+13970.6%
0.00%
Q2 2023$0320
+3100.0%
0.00%
Q1 2023$010
-9.1%
0.00%
Q4 2022$011
-95.8%
0.00%
Q3 2022$0
-100.0%
262
-31.1%
0.00%
Q1 2022$1,000
-66.7%
380
-62.7%
0.00%
Q4 2021$3,0001,018
+10080.0%
0.00%
Q4 2020$0
-100.0%
10
-99.4%
0.00%
Q3 2020$3,0000.0%1,544
+2.4%
0.00%
Q2 2020$3,0000.0%1,508
+9.6%
0.00%
Q1 2020$3,0000.0%1,376
+37.6%
0.00%
Q4 2019$3,000
+200.0%
1,000
-13.2%
0.00%
Q3 2019$1,0000.0%1,152
+15.2%
0.00%
Q2 2019$1,0000.0%1,0000.0%0.00%
Q1 2019$1,0000.0%1,0000.0%0.00%
Q4 2018$1,000
-88.9%
1,000
-36.0%
0.00%
Q3 2018$9,000
-18.2%
1,562
+56.0%
0.00%
Q2 2018$11,0001,001
+24925.0%
0.00%
Q1 2018$04
-92.0%
0.00%
Q4 2017$0
-100.0%
50
-97.2%
0.00%
Q3 2017$16,0001,800
+17900.0%
0.00%
Q2 2017$0
-100.0%
10
-99.4%
0.00%
Q1 2017$13,000
+225.0%
1,624
+282.1%
0.00%
Q4 2016$4,000
+33.3%
425
+112.5%
0.00%
Q3 2016$3,0002000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2018
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 3,917,622$7,365,0000.21%
GSA CAPITAL PARTNERS LLP 54,092$102,0000.06%
Carmignac Gestion 1,937,608$3,643,0000.05%
OXFORD FINANCIAL GROUP, LTD. LLC 91,824$173,0000.03%
SIGNATUREFD, LLC 121,351$228,0000.01%
Tekla Capital Management LLC 165,330$311,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 184,000$346,0000.01%
GROUP ONE TRADING, L.P. 567,903$1,068,0000.01%
Integrated Advisors Network LLC 15,700$30,0000.00%
WEDBUSH SECURITIES INC 22,900$43,0000.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders